Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis
Maria G. Tektonidou
Journal of Autoimmunity (2022) Vol. 128, pp. 102813-102813
Closed Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

A Novel Study on Machine Learning Algorithm-Based Cardiovascular Disease Prediction
Arsalan Khan, Moiz Qureshi, Muhammad Daniyal, et al.
Health & Social Care in the Community (2023) Vol. 2023, pp. 1-10
Open Access | Times Cited: 50
Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations
Pedro Gaspar, Savino Sciascia, Maria G. Tektonidou
Lara D. Veeken (2024) Vol. 63, Iss. SI, pp. SI24-SI36
Open Access | Times Cited: 19
Nanozyme as a rising star for metabolic disease management
Yanan Wang, Xiaoyun He, Kunlun Huang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Antiphospholipid antibodies positivity as a potential risk factor for restenosis following arteriovenous fistula stenting in hemodialysis patients: a pilot study
Maxime Taghavi, Adrien Lengelé, Marc Laureys, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access | Times Cited: 2
Metabolic syndrome in antiphospholipid syndrome versus rheumatoid arthritis and diabetes mellitus: Association with arterial thrombosis, cardiovascular risk biomarkers, physical activity, and coronary atherosclerotic plaques
Eleana Bolla, Nikolaοs Tentolouris, Petros P. Sfikakis, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 18
Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome
Rodrigo Aguirre del-Pino, Rory C. Monahan, T. Huizinga, et al.
Seminars in Thrombosis and Hemostasis (2024) Vol. 50, Iss. 06, pp. 817-828
Open Access | Times Cited: 7
TPTM-HANN-GA: A Novel Hyperparameter Optimization Framework Integrating the Taguchi Method, an Artificial Neural Network, and a Genetic Algorithm for the Precise Prediction of Cardiovascular Disease Risk
Chia-Ming Lin, Yu‐Shiang Lin
Mathematics (2024) Vol. 12, Iss. 9, pp. 1303-1303
Open Access | Times Cited: 7
Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries
Eleana Bolla, Anne Grete Semb, Anne M Kerola, et al.
The Lancet Rheumatology (2024) Vol. 6, Iss. 7, pp. e447-e459
Closed Access | Times Cited: 7
Atherosclerosis, Cardiovascular Disorders and COVID-19: Comorbid Pathogenesis
Yulia A. Makarova, Varvara A. Ryabkova, В. В. Салухов, et al.
Diagnostics (2023) Vol. 13, Iss. 3, pp. 478-478
Open Access | Times Cited: 16
Prevalence of Antiphospholipid Antibodies and Association With Incident Cardiovascular Events
Yu Zuo, Sherwin Navaz, Wenying Liang, et al.
JAMA Network Open (2023) Vol. 6, Iss. 4, pp. e236530-e236530
Open Access | Times Cited: 16
Seven-year follow-up atherosclerotic plaque progression in patients with antiphospholipid syndrome versus diabetes mellitus and healthy controls
Gerasimos Evangelatos, Nikolaοs Tentolouris, Petros P. Sfikakis, et al.
Lara D. Veeken (2024)
Open Access | Times Cited: 5
Aberrant expansion of CD177+ neutrophils promotes endothelial dysfunction in systemic lupus erythematosus via neutrophil extracellular traps
H. Xu, Minghua Zhan, Ziyan Wu, et al.
Journal of Autoimmunity (2025) Vol. 152, pp. 103399-103399
Closed Access
Anticoagulant and non-anticoagulant therapy in thrombotic antiphospholipid syndrome: old drugs and new treatment targets
Guillermo Ruiz‐Irastorza, Maria G. Tektonidou, Munther A. Khamashta
Lara D. Veeken (2024) Vol. 63, Iss. SI, pp. SI96-SI106
Closed Access | Times Cited: 4
A predictive model for premature atherosclerosis in systemic lupus erythematosus based on clinical characteristics
Ruyu Liang, Haojie Xu, Ranran Yao, et al.
Clinical Rheumatology (2024) Vol. 43, Iss. 5, pp. 1541-1550
Closed Access | Times Cited: 4
Coenzyme Q10 and Autoimmune Disorders: An Overview
David Mantle, Iain P. Hargreaves
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4576-4576
Open Access | Times Cited: 4
A Lipidomic Study to Identify the Serum Lipid Markers for Obstetric Antiphospholipid Syndrome
Zhaoer Yu, Yixiao Wang, Lili Fan, et al.
Journal of Proteome Research (2025) Vol. 24, Iss. 2, pp. 491-498
Closed Access
The Role of Immune Cells in Moyamoya Disease
Sheng Wang, Qian Jiang, Yuan Liu, et al.
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 137-137
Open Access
Immunomodulation for accelerated atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus
Elena Bartoloni, Fabio Cacciapaglia, Gian Luca Erre, et al.
Autoimmunity Reviews (2025), pp. 103760-103760
Closed Access
Longitudinal assessment of cerebral infarcts and small vessel disease using magnetic resonance imaging in antiphospholipid syndrome: A single‐centre retrospective study
Yishi Tan, Andrew J. Doyle, Jayant Kumar, et al.
eJHaem (2025) Vol. 6, Iss. 1
Open Access
Lupus nephritis as an independent risk factor for carotid atherosclerosis in patients with systemic lupus erythematosus
Yujiao Wang, Simin Guo, Yirui Shi, et al.
Clinical Rheumatology (2025)
Closed Access
Ocular markers of microangiopathy and their possible association with cardiovascular risk in patients with systemic inflammatory rheumatic diseases: a systematic review
Barbara Sturm, Aimin Zang, Julia C. Stingl, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Pregnancy-associated exposure reduction to medications used for antiphospholipid syndrome: a systematic review
Judith Zarek, Avery Brydon, Karen A. Spitzer, et al.
(2025) Vol. 1, Iss. 1, pp. 11-22
Open Access
Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome
Kleio‐Maria Verrou, Petros P. Sfikakis, Maria G. Tektonidou
Journal of Autoimmunity (2022) Vol. 134, pp. 102978-102978
Closed Access | Times Cited: 16
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry
Gustavo Guimarães Moreira Balbi, Yasaman Ahmadzadeh, Maria G. Tektonidou, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 3, pp. 772-779
Closed Access | Times Cited: 9
Biomarkers in Systemic Lupus Erythematosus along with Metabolic Syndrome
Fernanda-Isadora Corona-Meraz, Mónica Vázquez-Del Mercado, Flavio Sandoval-García, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1988-1988
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top